Mitomycin-C in the postsurgical ear canal
- PMID: 12825041
- DOI: 10.1016/S0194-59980300468-6
Mitomycin-C in the postsurgical ear canal
Abstract
Objective: Our goal was to evaluate the use of topical mitomycin-C (MMC) in the prevention of scar tissue formation in the postsurgical external auditory canal (EAC). Study design and setting We conducted a prospective pilot study at a tertiary care institution.
Methods: Six patients with recurrent postoperative granulation tissue after canaloplasty, tympanomastoidectomy, or lateral temporal bone resection were included. MMC (0.5 mg/mL) was applied topically for 5 minutes to the EAC/mastoid cavity.
Results: Outcomes were measured at initial MMC application and 1 and 3 months thereafter using a visual analog scale score based on the degree of EAC occlusion by granulation tissue. Need for debridement of recurrent granulation tissue on follow-up was noted. Three (50%) patients had improved VAS 1 month after treatment. Two (33%) had improved visual analog scale score at 3 months. Five (83%) required at least one debridement procedure. Repeat MMC application was performed in 2 patients.
Conclusion: Topical MMC was ineffective in preventing scar formation in the postsurgical EAC.
Similar articles
-
The preventive effect of mitomycin-C on the external auditory canal fibrosis in an experimentally induced animal model.Am J Otolaryngol. 2010 Jan-Feb;31(1):9-13. doi: 10.1016/j.amjoto.2008.08.013. Epub 2009 Mar 13. Am J Otolaryngol. 2010. PMID: 19944892
-
Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity.Otol Neurotol. 2005 Mar;26(2):140-4. doi: 10.1097/00129492-200503000-00002. Otol Neurotol. 2005. PMID: 15793395 Clinical Trial.
-
Intraoperative use of mitomycin C in fibrous atresia of the external auditory canal.Ear Nose Throat J. 2005 Dec;84(12):776-9. Ear Nose Throat J. 2005. PMID: 16408556
-
Imaging of postoperative middle ear, mastoid, and external auditory canal.Semin Ultrasound CT MR. 2002 Dec;23(6):460-5. doi: 10.1016/s0887-2171(02)90036-3. Semin Ultrasound CT MR. 2002. PMID: 12597094 Review. No abstract available.
-
Topical use of MMC in the upper aerodigestive tract: a review on the side effects.Eur Arch Otorhinolaryngol. 2010 Mar;267(3):327-34. doi: 10.1007/s00405-009-1151-0. Epub 2009 Nov 17. Eur Arch Otorhinolaryngol. 2010. PMID: 19921234 Free PMC article. Review.
Cited by
-
Potential risk of mitomycin C at high concentrations on peripheral nerve structure.Neural Regen Res. 2014 Apr 15;9(8):821-7. doi: 10.4103/1673-5374.131598. Neural Regen Res. 2014. PMID: 25206895 Free PMC article.
-
Topical application of mitomycin C in the treatment of granulation tissue after canal wall down mastoidectomy.Iran J Otorhinolaryngol. 2013 Spring;25(71):85-90. Iran J Otorhinolaryngol. 2013. PMID: 24303425 Free PMC article.
-
Effect of mitomycin on normal dermal fibroblast and HaCat cell: an in vitro study.J Zhejiang Univ Sci B. 2012 Dec;13(12):997-1005. doi: 10.1631/jzus.B1200055. J Zhejiang Univ Sci B. 2012. PMID: 23225855 Free PMC article.
-
[Systemic corticoid application in combination with topical mitomycin or dexamethasone. Inhibition of wound healing after tympanic membrane perforation].HNO. 2005 Sep;53(9):779-83. doi: 10.1007/s00106-004-1173-2. HNO. 2005. PMID: 15517118 German.
-
Anatomy and Development of the Mammalian External Auditory Canal: Implications for Understanding Canal Disease and Deformity.Front Cell Dev Biol. 2021 Jan 8;8:617354. doi: 10.3389/fcell.2020.617354. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33553153 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
